Freehold, NJ -- April 5, 2016 -- InvestorsHub NewsWire -- MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the “company” or “Medifirst”) would like to continue to update shareholders on recent developments regarding its FDA 510(k) submission for The Time Machine Laser Series.

Medifirst is pleased to announce that its The Time Machine Laser Series engineers have upgraded the lasers and made them more durable in addition to successfully making several internal modifications as requested as part of the FDA review process. The Company has upgraded its laser device with new components including an improved LCD screen that makes the device not only more durable but easier to repair in the unlikely case of an accident. Additionally, these upgrades can help expedite repairs and possibly avoid extensive delays that could involve the lasers having to be shipped back to the manufacturer.

The Company is also pleased to announce that the Time Machine Laser has successfully passed five laboratory tests as required by the FDA as part of the EMC evaluation currently being conducted and the team continues to work diligently to complete the testing process. Commented CEO Bruce J. Schoengood, “We continue to work with our team to expeditiously respond to all requests towards completion of the testing phase as part of the FDA review process. Working with our experienced team of laser engineers, our goal is to provide hospitals, surgical centers and healthcare professionals with our Laser Series that meets all FDA standards as required for a hand-held laser device.”  

Regarding International sales, the Company has preformed several demonstrations and have received very strong interest from distributors in the UK, Australia, Russia and Brazil. The Company is currently preparing to initiate a national and international sales strategy upon successfully getting the 510(k) clearance from the FDA.  
 

About Medifirst Solutions, Inc.
Medifirst Solutions, Inc. is a Nevada corporation that is headquartered in New Jersey. The company seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals, as well as everyday consumers. Medifirst is developing and establishing both consumer and professional medical cliental that can serve as a pipeline that will allow for distribution of future products and services. For more details visit www.medifirstsolutions.com for more information.

About the Lasers
Medical Lasers Manufacturer, Inc., a Nevada company, (“MLM”), a Medifirst subsidiary, will specialize in producing high quality diode-pumped solid-state lasers. The laser division, including products and treatment programs, will be operated out of MLM. The company’s focus is to help patients with specific cosmetic skin conditions, as well as relief of muscle and joint pain and muscle spasm and inflammation. Driven by the huge demand for minimally invasive skin and pain treatments, the global market for medical and therapeutic lasers have been estimated to grow as high as to $4 billion in 2015.


Forward-Looking Statements:  The statements in this press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control.  Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission.  Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.  We make no commitment to disclose any subsequent revisions to forward-looking statements.


Contact:    Investor Relations
Phone:      (732) 786-8044
Email:        info@medifirstsolutions.com
Website:    www.medifirstsolutions.com